A [60]fullerene Nanoconjugate With Gemcitabine: Synthesis, Biophysical Properties and Biological Evaluation for Treating Pancreatic Cancer

Cancer Nanotechnology - United States
doi 10.1186/s12645-020-00058-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Synthesis and Biological Activity of a Gemcitabine Phosphoramidate Prodrug

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2007English

Stereodivergent-At-Metal Synthesis of [60]Fullerene Hybrids

Angewandte Chemie - International Edition
CatalysisChemistry
2017English

Linear and Nonlinear Optical Properties of [60]Fullerene Derivatives

Journal of Physical Chemistry A
MedicineTheoretical ChemistryPhysical
2009English

Synthesis and Properties of Fullerene Nanowhiskers

Hyomen Kagaku
2007English

Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Cancer Management and Research
Oncology
2018English

Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer

Suizo
2007English

Synthesis of a Novel [60]fullerene Pearl-Necklace Polymer, Poly(4,4?-Carbonylbisphenylenetrans-2-[60]fullerenobisacetamide)

Journal of Polymer Science, Part A: Polymer Chemistry
Organic ChemistryPolymersMaterials ChemistryPlastics
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy